- Home
- / Ginkgo Bioworks
Ginkgo Bioworks
Stock Price
$1.6
2023-11-15
Market Capitalization
$3.3 B
2023-11-15
Revenue
$477.7 M
FY, 2022
Ginkgo Bioworks Summary
Company Summary
- Overview
- Ginkgo Bioworks is a company that designs, engineers and develops living organisms from DNA codes. It offers enzyme discovery, protein production, metabolic engineering, strain optimization, and other services. The company caters to agriculture, biopharmaceutical, government, industrial, nutrition, and other sectors.
- Type
- Public
- Status
- Active
- Founded
- 2008
- HQ
- Boston, MA, US | view all locations
- Cybersecurity rating
- ESG rating
- Sectors
Table of Contents
Key People
Austin Che, Founder
Reshma Shetty, Co-Founder & President, COO, Director
Tom Knight, Founder
Ginkgo Bioworks Financials
Summary Financials
- Revenue (Q3, 2023)
- $55.4M
- Net income (Q3, 2023)
- ($302.9M)
- Cash (Q3, 2023)
- $1.0B
- EBIT (Q3, 2023)
- ($286.4M)
- Enterprise value
- $2.7B